SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
Clinical & Translational Immunology2021Vol. 10(7), pp. e1306–e1306
Citations Over TimeTop 10% of 2021 papers
John Tyler Sandberg, Renata Varnaitė, Wanda Christ, Puran Chen, Jagadeeswara Rao Muvva, Kimia T. Maleki, Marina García, Majda Dzidic, Elin Folkesson, Magdalena Skagerberg, Gustaf Ahlén, Lars Frelin, Matti Sällberg, Lars I. Eriksson, Olav Rooyackers, Anders Sönnerborg, Marcus Buggert, Niklas K. Björkström, Soo Aleman, Kristoffer Strålin, Jonas Klingström, Hans‐Gustaf Ljunggren, Kim Blom, Sara Gredmark‐Russ, The Karolinska COVID‐19 Study Group
Abstract
Our findings describe the initiation and, importantly, persistence of cellular and humoral SARS-CoV-2-specific immunological memory in hospitalised COVID-19 patients long after recovery, likely contributing towards protection against reinfection.
Related Papers
- → Evolutionary Mechanisms of Defense Reactions(1998)12 cited
- [Clinical features and cellular immunity in patients with icterohemorrhagic leptospirosis].(1995)
- Applications of humoral and cellular immunity in classification between qi deficiency and blood deficiency syndrome(2011)
- The changes of cellular and humoral immunity in 144 cases of hand,foot and mouth disease children(2011)
- [Local cellular and humoral immunity in pneumonia patients].(2000)